Jun 16, 2022 / 03:00PM GMT
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
We're ready to get going here. All right. Welcome, everybody. Amit Hazan, medical technology analyst at Goldman. And this is the final day of the Goldman Healthcare Conference.
And here to take us home, so to speak, is Becton Dickinson. Really excited for this conversation. We have both Chris DelOrefice, the Chief Financial Officer, here with us today. And we've got Simon Campion, who is the, technically, Executive Vice President of Interventional, but as of last week, EVP of Medical as well. So congrats on that role.
Simon D. Campion - Becton, Dickinson and Company - Executive VP & President of Interventional Segment
Thank you.
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
We can get into that as well. But -- welcome to you. And it's been an exciting week, to say the least, as you might imagine. Some of the conversations have focused on the macro stuff going on. We can't avoid it.
And I think
Becton Dickinson and Co at Goldman Sachs Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot